Effectiveness and tolerability of a standardized extract from Ageratina pichinchensis on patients with tinea pedis: An explorative pilot study controlled with ketoconazole

Planta Medica

Volumn 72, Issue 14, 2006, Pages 1257-1261

  Romero Cerecero, Ofelia ^a   Rojas, Gabriela ^a   Navarro, Víctor ^a   Herrera Arellano, Armando ^a   Zamilpa Álvarez, Alejandro ^a   Tortoriello, Jaime ^a  

^a INSTITUTO MEXICANO DEL SEGURO SOCIAL   (Mexico)

Author keywords

Ageratina pichinchensis; Asteraceae; Axihuitl; Benzofurans; Complementary and alternative medicine; Dermatomycosis; Dermatophyte; Superficial mycosis; Tinea pedis

Indexed keywords

AGERATINA PICHINCHENSIS EXTRACT; HERBACEOUS AGENT; KETOCONAZOLE; PLANT EXTRACT; UNCLASSIFIED DRUG;

ADULT; AGED; AGERATINA PICHINCHENSIS; ANTIFUNGAL ACTIVITY; ARTICLE; ASPERGILLUS NIGER; CANDIDA ALBICANS; CLINICAL FEATURE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRUG EFFICACY; DRUG TOLERABILITY; FEMALE; FUNGUS CULTURE; HUMAN; IN VITRO STUDY; MAJOR CLINICAL STUDY; MALE; MEDICINAL PLANT; MICROSCOPY; NONHUMAN; PILOT STUDY; RANDOMIZED CONTROLLED TRIAL; TINEA PEDIS; TRICHOPHYTON MENTAGROPHYTES; TRICHOPHYTON RUBRUM; UNSPECIFIED SIDE EFFECT;

ADMINISTRATION, CUTANEOUS; ADOLESCENT; ADULT; AGED; AGERATINA; ANTIFUNGAL AGENTS; ARTHRODERMATACEAE; DOUBLE-BLIND METHOD; FEMALE; HUMANS; KETOCONAZOLE; MALE; MIDDLE AGED; PHYTOTHERAPY; PILOT PROJECTS; PLANT COMPONENTS, AERIAL; PLANT EXTRACTS; SEVERITY OF ILLNESS INDEX; TINEA PEDIS; TREATMENT OUTCOME;

AGERATINA; ARTHRODERMA BENHAMIAE; ASTERACEAE; CANDIDA ALBICANS; TINEA PEDIS; TRICHOPHYTON RUBRUM;

EID: 33845264837     PISSN: 00320943     EISSN: None     Source Type: Journal    
DOI: 10.1055/s-2006-951694     Document Type: Article

References (22)

1. Zurita EM, Zolla C. Enfermedades dermatologicas en la medicina tradicional de México. Bol Oficina Sanit Pan 1986; 101: 339-44
2. Argueta A, Cano L, Rodarte M. Atlas de la medicina tradicional Mexicana, tomo1 - 3. Instituto Nacional Indigenista: México D.F, 1994: 1786
3. Aviles M, Suárez G. Catalogo de plantas medicinales. Jardín Etnobotánico Centro INAH, Cuernavaca, Morelos, México: 1994: 47
4. Monroy-Ortiz C, Castillo-España P. Plantas medicinales utilizadas en Morelos. México: Centro de Investigaciones Biológicas Universidad Autónoma del Estado de Morelos, 2000: 61-2
5. Rzedowski GC, Rzedowsky J. Flora fanerogámica del Valle de México. Centro Regional del Bajío. Comisión Nacional para el Conocimiento y Uso de la Biodiversidad. Patzcuaro, Michoacán. Instituto de Ecología A.C. 2nd Edition. 2001: 797
6. Gómez F, Quijano L, Calderón JS, Perales A, Rios T. 2,2-Dimethylchromenes from Eupatorium aschembornianum. Phytochemistry 1982; 21: 2095-7
7. Navarro VM, García A, González M, Fuentes A, Aviles M, Rios Y et al. Antifungal activities of nine traditional Mexican medicinal plants. J Ethnopharmacol 2003; 87: 85-8
8. Rios MY, Aguilar-Guadarrama B, Navarro VM. Two new benzofurans from Eupatorium aschenbornianum and their antimicrobial activity. Planta Med 2003; 69: 967-70
9. Porta-Aponte T, Olivera-Fernández A, Palma-Mora S, Monteaguado GL, González-Pérez D. Pruebas dérmicas y oftálmicas a un extracto etanólico de Bixa orellana. Medicentro 2001; 5: 1-5
10. Wade-Foster K, Ghannoum MA, Eleweski BE. Epidemiologic surveillance of cutaneous fungal infection in the United States from 1999 to 2002. J Am Acad Dermatol 2004; 50: 748-52
11. Cordeiro RA, Brilhante RS, Rocha MF, Rabenhorsch SH, Moreira JL, Grangeiro TB et al. Antifungal susceptibility and genetic similarity of sequential isolates of Trichophyton rubrum from an immunocompetent patient whit chronic dermatophytosis. Clin Exp Dermatol 2006; 31: 122-4
12. Ghannoum MA, Hossain MA, Long L, Mohamed S, Reyes G, Hukherjee PK. Evaluation of antifungal efficacy in an optimized animal model of trichophyton mentagrophytes-dermatophytosis. J Chemother 2004; 16: 139-44
13. Gupta AK. The treatment of chronic interdigital tinea pedis infection using imiquimod cream 5%. J Am Acad Dermatol 2004; 50 (Suppl. 1): 104
14. Porche DJ. Tinea pedis: a common male foot problem. J Nurse Pract 2006; 2: 152-3
15. Gupta AK, Ryder JE, Chow M, Cooper EA. Dermatophytosis: the management of fungal infections. Skinmed 2005; 4: 305-10
16. Hoharitanon S, Chaichalotornkul J, Sindhupak W. A comparison of the efficacy between two itraconazole generic products and the innovative utraconazole in the treatment of tinea pedis. J Med Assoc Thai 2005; 88 (Suppl. 4): 167-72
17. Herrera-Arellano A, Rodríguez-Soberanes A, Martinez-Rivera MA, Martinez-Cruz E, Zamilpa A, Alvarez L et al. Effectiveness and tolerability of standardized prhytodrug derived from Solanum chrysotrichhum on tinea pedis: a controlled and randomized clinical trial. Planta Med 2003; 69: 390-5
18. Menendez S, Falcon L, Simon DR, Landa N. Efficacy of ozonized sunflower oil in the treatment of tinea pedis. Mycoses 2002; 45: 329-32
19. Puiatti P, Cervetti O, Forte M, Zina G. Ketokonazole treatment in superficial mycosis. Drugs Exp Clin Res 1986; 12: 405-7
20. Greer DL. Topical treatment for mocasín-type tinea pedis. J Am Acad Dermatol 1987; 16: 554-8
21. Greer D, Jolly HW. Comparative trial of a two-dosage schedule of ketoconazole 2% cream for the treatment of tinea pedis. J Am Acad Dermatol 1987; 17: 53-6
22. Lester M. Ketoconazole 2 percent cream in the treatment of tinea pedis, tinea cruris and tinea corporis. Cutis 1995; 55: 181-3